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Abstract
Background Dynamic optical coherence tomography (D-OCT) allows in vivo visualization of blood vessels in the skin
and in malignant tumours. Vessel patterns in malignant melanoma may be associated with tumour stage.
Objective The aim of this study was to describe blood vessel patterns in melanomas and to correlate them with stage.
Methods One hundred fifty-nine malignant melanomas were assessed in a multicentre study. Every tumour was
imaged using D-OCT prior to surgery and histologic evaluation. The tumour data such as thickness and ulceration as
well as the staging at primary diagnosis and a follow-up of at least 40 months resulted in a stage classification. The ves-
sel patterns were assessed according to predefined categories, compared with healthy adjacent skin, and correlated to
stage.
Results Melanomas contained more blood vessels in different patterns compared with healthy adjacent skin. In partic-
ular, irregular vascular shapes such as blobs, coils, curves and serpiginous vessels were more common in melanomas.
In addition, these patterns were significantly more often found in high-risk and metastatic melanomas than in low-risk
lesions.
Conclusion In melanomas, the density of the blood vessels is increased, and irregular vascular patterns are more fre-
quent. At higher stages, especially in metastatic melanomas, these atypical vessels are significantly more common.
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Introduction
Malignant tumours, especially malignant melanomas, often
exhibit a higher density of blood vessels compared with adjacent
tissue. These vessels not only feed the growing tumour but also
enable haematogenic spread of tumour cells. The process of
tumour vascularization proceeds through multiple different
mechanisms such as sprouting, intussusceptive angiogenesis,
vascular co-option, mosaic vessels, vasculogenic mimicry and
bone-marrow-derived vasculogenesis,1,2 which are driven by
interaction between tumour cells, endothelial cells and immune
cells in the surrounding tissue.1 Hypoxia seems to be an impor-
tant factor for triggering angiogenesis.3,4,5 Because it plays such
an important role, angiogenesis is an interesting target for anti-
tumour therapy.2,6
Blood vessels play a role in three out of five steps of metasta-
sis: intravasation, circulation and extravasation of tumour cells.7
Several studies focused on the quantification of intra- and peri-
tumoral vessels, using immunohistochemistry staining of histo-
logic sections and counting the microvessels.8 Some studies have
shown that intratumoral blood vessel density is associated with
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the risk of organ metastasis.8,9 The results were sometimes con-
tradictory, and a review demonstrated that the microvessel den-
sity in melanoma still cannot be recommended as a basis for
making clinical decisions.1
Existing methods to evaluate blood vessels have limitations.
In dermoscopy, atypical blood vessels have been described in
malignant melanomas,10 but pigmentation of the melanoma
often obscures the vessels. In histologic sections, the blood
vessels collapse after excision, fixation and staining, and fur-
thermore, histology only provides a two-dimensional section
and gives little idea of the three-dimensional vessel network
in the tumour. It is well known that the architecture of the
tumour influences areas of hypoxia and angiogenesis.3,4,5
Therefore, there is a high and so far unmet need for a non-
invasive in vivo method to obtain 3D images of skin
microvasculature.
Dynamic optical coherence tomography (D-OCT), also called
OCT angiography, is a new, non-invasive tool to visualize blood
vessels in the skin in vivo in three dimensions.
Initial studies have shown distinct vessel patterns in healthy
and diseased skin.11,12 The vasculature allows a differentiation
between different types of non-melanoma skin cancer and of
subtypes of basal cell carcinoma.13,14 A case report of a naevus-
associated malignant melanoma showed an increased vascula-
ture in the melanoma region compared with the naevus.15 A
study of 127 melanomas showed a strong correlation between
vascular patterns and Breslow’s thickness.16
Here, we report on the relation between qualitative and quan-
titative aspects of tumour microvasculature with known risk fac-
tors for metastasis and stage.
Materials and methods
Consecutive patients with malignant melanomas were recruited
for the study after informed consent. D-OCT imaging of the
centre of the tumour and of healthy adjacent was performed.
Finally, the patients underwent excision of the tumour and,
depending on local guidelines, further staging and surgery of the
sentinel lymph node.
After surgery, the results of the tumour histology, of the status
of sentinel node (if biopsy was performed) of the primary stag-
ing (American Joint Committee on Cancer 8th edition17) and of
follow-up for at least 40 months resulted in a classification as
follows:
• Risk group 1 (low risk): in situ melanoma and stage IA
(thickness ≤1 mm).
• Risk group 2 (intermediate risk): stage IB to stage IIB (in-
termediate thickness with or without ulceration).
• Risk group 3 (high risk): stage IIC (ulcerated melanoma
>4 mm), stage III (lymph node involvement) and stage IV
(distant organ metastases).
The D-OCT device VivoSight Dx was developed and CE-
marked for the project (Michelson Diagnostics Ltd., Maidstone,
UK, www.vivosight.com/researcher/regulatory). All four centres
(three hospital settings and a private practice) used the same
configuration of the system: lateral resolution <7.5 µm, axial
resolution <10 µm (in tissue) and image pixel size 4.3 µm. OCT
image depth penetration is ~1 mm, but D-OCT is limited to
depth 0.5 mm. Minimum detected vessel diameter is 20 µm due
to the speckle variance detection technique with repetitive scans
of the same site.
From the centre of each melanoma (respectively, the clinically
most relevant site, avoiding scars from previous biopsies), a
6 mm 9 6 mm area was imaged in the dynamic mode, taking
30 s, producing 120 cross-sectional images with a spacing of
50 µm between the images. Thus, the scanning process resulted
in a three-dimensional image ‘block’ of volume
6 mm 9 6 mm 9 2 mm (width 9 length 9 depth), in which
the brightness of the pixels corresponds to tissue structural
details and red pixels correspond to blood vessels. The vessels in
D-OCT can only be assessed to a depth of approximately
500 µm, because at greater depths noise in the OCT signal inter-
feres with the speckle variance detection of motion. In addition,
the adjacent healthy skin was measured with the same settings at
a distance of 5 mm from the visible tumour border.
The images were evaluated by three investigators (JW, SS and
NC) independently, all blinded for site and tumour parameters.
In case of discrepancy (<10% of the individual OCT pictures),
the images were discussed together, and a unanimous consensus
was found. All three observers were trained beforehand to apply
the parameters.
The previously proposed terminology for standardized
description of the D-OCT images, which all investigators
were involved in developing, was used.18 Briefly, the blood
vessels were assessed at a depth of 150 and 300 µm in the en
face images regarding density, diameter, distribution (regular,
irregular or clustered) and direction (no orientation, stream-
ing or radiating) of the vessels. Density and diameter were
compared with healthy adjacent skin (less, average or more)
being the internal reference. Then, the shapes of the vessels
were described using the terms dots, blobs, coils, lines, curves
and serpiginous vessels. Each shape was rated 0 = absent or
1 = present. The depths of 150 and 300 µm correspond to
the depths of dermal papillae and the reticular dermis in typ-
ical healthy skin.
Statistical evaluation was performed using the Wilcoxon test
for matched pairs when comparing the melanoma with healthy
adjacent skin. Comparison between the tumours was done using
the Kruskal–Wallis H-tests, followed by the Mann–Whitney U-
test if there was an indication for significance, which was
assumed at P ≤ 0.05. Due to low case numbers in the individual
subgroups, no multivariate logistic regression analysis was per-
formed.
All local ethics committees of the study centres approved the
study.
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Results
Malignant melanomas
A total of 160 malignant melanomas from 156 patients were
evaluated by D-OCT before excision. One patient had three
simultaneous melanomas, another two. The mean age of the
patients (52 female and 104 male) was 65 years. One patient
declined surgery because of his general poor health condition
and dropped out of the study, leaving 159 cases for evaluation.
In 81 cases, the adjacent skin was also imaged. Twelve melano-
mas of the included tumours were biopsied before imaging, all
others were not. After imaging, the standard procedure of exci-
sion with safety margin and – depending on the tumour param-
eters – sentinel node biopsy and staging were performed in all
patients.
This resulted in 23 cases where the sentinel lymph node was
excised, thereof seven cases with melanomas of <1 mm thickness
because of additional factors such as mitosis or ulceration. Four
patients exhibited macrometastasis of the lymph nodes at time
point of primary staging before surgery.
Regarding the subtype of melanoma, 107 melanomas were
classified as superficial spreading melanomas. Twenty-three were
nodular, two were acrolentiginous and 21 were lentigo maligna
or invasive lentigo maligna melanomas. Six melanomas could
not be classified. Twenty-one melanomas were ulcerated.
Looking at invasion levels, 42 melanomas were classified as
in situ melanomas and 75 invasive melanomas were up to 1 mm
thick. The tumour thickness of 18 melanomas ranged between 1
and 2 mm, of 13 melanomas between 2 and 4 mm, and 11 mela-
nomas were thicker than 4 mm. The tumour thickness accord-
ing to Breslow was on average 1.29 mm (range from in situ
melanomas to 18 mm thickness).
During follow-up (range: 40–65 months, median: 51 months
after first diagnosis), 15 patients were classified in a higher-risk
category due to metastases, resulting in an up-staging.
Finally, 103 melanomas were classified as risk group 1, 30
were classified as risk group 2, and 26 were assigned to risk
group 3 from stage IIC with a thick, ulcerated tumour (three
cases), stage III (seven cases) with lymph node involvement to
stage IV (16 cases) with distant organ metastases.
D-OCT
In all melanomas, it was possible to visualize the three-dimen-
sional vessel network with D-OCT. In the en face view at a depth
of 150 µm, dots are the predominant vessel pattern, representing
the capillary loops in the papillary dermis, whereas the images at
300 µm show a great variety of vessel patterns.
In 81 cases, the healthy adjacent skin was imaged and evalu-
ated as well. In these cases, the density of blood vessels was lower
in 3% of the melanomas, equal in 59% and higher in 38% com-
pared with healthy skin as internal reference. The diameter of
the melanoma vessels was equal to healthy skin in 83% and
larger than healthy skin in the remaining 17%. Melanin did not
seem to have a significant influence on the image quality and sig-
nal intensity of the vessels; D-OCT images of vessels in hypome-
lanotic melanomas did not appear different from those of highly
pigmented tumours. Melanomas show a larger number of differ-
ent vessel patterns compared with healthy skin. At 150 µm, all
patterns are more frequently found in melanomas, reaching sig-
nificance for dots (P = 0.02), blobs (P = 0.002), lines
(P = 0.04), curves (P = 0.002) and serpiginous vessels
(P = 0.007). Dots were the most common pattern at 150 µm
depth, whereas at 300 µm, all different patterns were found. At
that depth, again all patterns were more frequent in melanomas
compared with healthy skin at the same depth, reaching signifi-
cance for coils (P = 0.0002), curves (P = 0.01) and serpiginous
vessels (P = 0.004); see Fig. 1. Even in the risk group 1 with
in situ and thin melanomas, where 42 melanomas were thinner
than 150 µm and another 11 cases between 150 and 300 µm, all
patterns were more frequent in the melanomas compared with
healthy skin, indicating that also subtumoral vessels were
affected by the tumour above. Additionally, melanomas show
more often an irregular distribution of the vessels (P = 0.0002)
and an atypical branching such as arborizing vessels or bulges
(P = 0.03). Fig. 2 shows an example of a melanoma with coils
and serpiginous vessels to demonstrate the atypical shapes.
The presence of blobs, curves, coils and serpiginous vessels
and the degree of irregular distribution of these patterns corre-
lated significantly with the risk of metastasis. At a depth of
150 µm, significantly more blobs (P < 0.0001), more coils
(P = 0.0006), more curves (P = 0.007) and more serpiginous
vessels (P < 0.0001) as well as an atypical branching
(P < 0.0001) in risk group 3 compared with risk group 1 were
found. At a depth of 300 µm, significantly less dots (P = 0.046),


































Figure 1 Percentage of vessel patterns in melanomas (MM) and
corresponding healthy skin (HS) at a depth of 300 µm, n = 81. All
patterns except dots are more frequently found in melanomas
compared with healthy adjacent skin.
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serpiginous vessels (P = 0.007) in risk group 3 compared with
risk group 1 also reflect this (Table 1, Fig. 3).
In addition, the density of the blood vessels and the diameter
were significantly more often increased in high-risk compared
with low-risk melanomas at 300 µm (P = 0.03 resp. P = 0.01);
see Fig. 4.
Even in risk group 3, there was a difference between non-
metastatic high-risk or lymphogenically metastasized melanomas
and those with haematogenic distant metastasis. Only 60% of
stage IIC and stage III melanomas showed coils or serpiginous
vessels, while 88% of haematogenously spread melanomas in
stage IV showed coils and 97% serpiginous vessels.
Nodular melanomas have coils (P = 0.01) and serpiginous
vessels (P = 0.01) significantly more often compared with the
other subtypes. Also, ulceration correlated significantly with the
presence of coils (P = 0.001) and serpiginous vessels (P = 0.03).
Discussion
Dynamic OCT (D-OCT) is a newly developed addition to mor-
phologic OCT that allows a simultaneous display of skin blood
vessels in vivo and real time.11 In the present study, we systemati-
cally evaluated vessel density and shape in 159 D-OCT scans of
malignant melanomas and correlated the findings with healthy
adjacent skin, other known categorical risk factors and observed
metastasis. We confirmed that D-OCT enables the in vivo, real-
time and non-invasive visualization of the blood vessel network
in malignant melanomas.11–16 In general, melanomas show more
often a higher vessel density and larger vessel diameter, a higher
prevalence of distinct vessel patterns, more irregular distribution
of vessels and presence of atypical branching and special shapes
such as coils and serpiginous vessels compared with healthy skin
of the same location as an internal control, even in very thin or
in situ lesions. This indicates that angiogenesis occurs very early
in tumour progression and invasion.
There are also some studies using OCT angiography for the
assessment of vessels in choroidal and iris melanomas.19,20 In the
iris, melanomas showed an increased vascularity and more atypi-
cal vessels similar to our findings.19
Dynamic-OCT results correspond to dermoscopy, where
malignant melanomas also exhibit atypical vessels,10 especially in
fast-growing melanomas, indicating angiogenesis in thicker
tumours.21,22 It has been demonstrated that some other dermo-
scopic features correlate with positive sentinel nodes such as
micro-ulceration, pigment blotches and absence of pigment net-
work.23 It is notable that melanoma vessels are described dermo-
scopically mainly in hypomelanotic tumours because overlying
pigmentation makes it difficult to assess the vasculature. Inter-
estingly, melanin had no influence on the presentation of vessels
in D-OCT, because it has a very low absorption coefficient at the
D-OCT wavelength (1300 nm) and so is nearly transparent.24
We had highly pigmented and amelanotic melanomas in our
study, both could be evaluated without visible differences.
In contrast to OCT, dermoscopy only allows assessment of
very superficial vessels because the detection depth of visible
light is limited in a highly scattering medium like skin. Dotted
vessels or even areas without visible vessels are described in der-
moscopy of melanomas.10 This is no contradiction to our find-
ings, because in addition to superficial images with increased
number or irregularly distributed dots and blobs in melanomas
we focus on the vasculature inside the tumour at a depth of
300 µm, which is out of reach of dermoscopy.
In our study, the atypical shapes of vessels such as blobs,
curves, coils and serpiginous vessels increase with higher stage of
disease.
Figure 2 Dynamic optical coherence tomography of a malignant
melanoma at the back, tumour thickness 2.2 mm, ulceration,
pT3bN0M0, St. IIB, risk group 2. The predominant vessel patterns
are coils (marked by small coils) and serpiginous vessels with atyp-
ical branching (marked by arrows). En face view at a depth of
300 µm, 6 mm 9 6 mm, scale bar 1 mm.
Table 1 Vessel patterns in relation to risk at a depth of 150 and
300 µm
150 µm R1 (n = 103) R2 (n = 30) R3 (n = 26)
Dots 99% (102) 100% (30) 96% (25)
Blobs 12% (12) 37% (11) 35% (12)
Coils 5% (5) 17% (5) 23% (7)
Lines 11% (11) 13% (4) 23% (6)
Curves 17% (17) 43% (13) 35% (11)
Serpiginous vessels 4% (4) 7% (7) 31% (10)
300 µm R1 (n = 103) R2 (n = 30) R3 (n = 26)
Dots 100% (103) 100% (30) 96% (25)
Blobs 83% (85) 93% (28) 81% (21)
Coils 51% (53) 73% (22) 77% (20)
Lines 69% (71) 53% (16) 46% (12)
Curves 77% (79) 93% (28) 81% (21)
Serpiginous vessels 51% (53) 73% (22) 81% (21)
Risk 1 = MIS to stage IA, risk 2 = stage IB to stage IIB and risk 3 = stage IIC
to stage IV. Values as percentage % (n). Significant increase compared to
R1 is marked light brown at P < 0.05 and brown at P < 0.01. Significant
decrease compared to R1 is marked light green at P < 0.05.
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Studies counting blood vessels in hotspots in histologic sec-
tions are heterogeneous, but in general agreement with our find-
ings.8 A meta-analysis showed no clear trend towards a
correlation of microvessel density with the risk of metastasis.1
We propose that this can be largely explained by the differences
in methodology. It is very difficult to evaluate the shape of a
blood vessel in a cross-sectional histologic slide. Many of the
tumour vessels build a horizontal network above and around the
tumour in addition to intratumoral vertical vessels.8 In contrast
to histologic sections, D-OCT provides a three-dimensional
insight into a tissue block, allowing assessment of vessel patterns
in en face and in cross-sectional planes.
In a previous systematic study of a smaller number of melano-
mas,16 the increase in the Breslow stage was correlated with
more irregular distribution of dotted vessels and presence of
curved, coiled and serpiginous vessels in thicker melanomas.
The findings suggested that vascular changes described in D-
OCT might be correlated with neoangiogenesis related to
increased tumour burden and dermal invasion.
In our present study, atypical vessels were not only corre-
lated with tumour thickness. In the subgroup of melanomas
with metastasis at the time point of primary diagnosis, the
tumour thickness ranged between 1.2 and 10.5 mm. Coils
and serpiginous vessels more frequently accompany nodular
and ulcerated melanomas, reflecting the fact that tumour
thickness and ulceration status correlate with metastasis as
well. Both patterns are more frequent in melanomas with
haematogenic spread compared to melanomas with solely
lymph node metastasis, indicating that they are a marker for







































Figure 3 Percentage of vessel patterns at a depth of 150 and 300 µm in different risk classes of melanomas. Risk 1 = MIS to stage IA,
risk 2 = stage IB to stage IIB and risk 3 = stage IIC to stage IV. Dots are the predominant pattern at both depths. At 150 µm, all patterns
except dots increase with higher stage. At 300 µm, especially coils and serpiginous vessels are more frequently found in medium- to
high-risk melanomas compared with lower stage.
Figure 4 (a) Dynamic optical coherence tomography of a malig-
nant melanoma of risk group 1, St. IA, (b) healthy adjacent skin of
(a). The centre of the tumour (a) showed an increased vessel den-
sity with polymorphous vessels compared with healthy adjacent
skin (b). (c) demonstrates a malignant melanoma of risk group 2,
and (d) shows a metastatic malignant melanoma of risk group 3.
The vessel density and diameter as well as the number of atypical
vessel shapes such as coils (marked by small coils) increase with
higher risk. The vessels are distributed irregularly with clustered
vessels (arrow). En face view at a depth of 300 µm,
6 mm 9 6 mm.
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low risk after excision and staging exhibited ulceration, coils
and serpiginous vessels all together.
Optical coherence tomography and high-frequency ultra-
sound can be used to estimate the thickness non-invasively prior
to surgery.25,26,27 Because penetration depth of the signal is lim-
ited to about 1 mm, OCT was found to be superior to ultra-
sound in thinner tumours, but inferior in thicker ones.
Raster-scan optoacoustic mesoscopy (RSOM) is another, so
far still experimental option to visualize tumour vessels in vivo.
A first study of a melanoma model in four mice showed vascular
images with a lower resolution and significantly higher detection
depth (imaging of vessels at a depth of about 900–2000 µm)
compared with OCT. The method is not yet approved for in vivo
measurements in humans.28
Using OCT for risk assessment may include D-OCT not only
to assess vessel morphology, but also to estimate tumour thick-
ness. In addition to ulceration, which can be detected by the
naked eye, the other risk factors for higher stage and metastasis
can be non-invasively assessed prior to biopsy of surgery by inte-
grating D-OCT into the primary staging. Thus, the clinical benefit
for patients using dynamic OCT at the time of primary diagnosis
prior to surgery is especially for melanomas of the medium-risk
category of the preoperative estimation of tumour thickness and
the non-invasive detection of additional risk factors due to atypi-
cal vessel patterns, which may indicate metastasis.
The study has some limitations: The assessment of the vessel
morphology follows a terminology consensus but is nevertheless
subjective. Automated image analysis with integrated deep learn-
ing may provide a more objective tool to assess blood vessels in
the skin. In addition, D-OCT only displays blood vessels, but
lymphatic vessels may also play a role in metastatic growth. Mul-
tivariable analyses will need more cases to discern whether the D-
OCT can provide additional prognostic information to the tradi-
tional clinical–pathological risk factors in melanoma.
To conclude, D-OCT enables the assessment of tumour vessels
in malignant melanomas. Melanomas exhibit more blood vessels
with atypical shapes such as coils and serpiginous vessels with an
irregular distribution compared with healthy adjacent skin due to
neoangiogenesis of the tumour. In addition, the atypical vessel
patterns correlate with stage. Therefore, the assessment of blood
vessel morphology in malignant melanomas provides an addi-
tional possibility of risk estimation prior to surgery.
Acknowledgements
We thank Thomas Zwingers for help with the statistics and
data interpretation. The project is part of the ADVANCE
project that has received funding from the European Union’s
ICT Policy Support Programme as part of the Competitive-
ness and Innovation Framework Programme. The manuscript
reflects only the author’s views, and the European Union is
not liable for any use that might be made of information
contained herein.
IRB approval
The study has been approved by the local ethics committee of
Augsburg (30-14). Informed consent was obtained from all
patients.
References
1 Pastushenko I, Vermeulen PB, Van den Eynden GG et al. Mechanisms of
tumour vascularization in cutaneous malignant melanoma: clinical impli-
cations. Br J Dermatol 2014; 171: 220–233.
2 Felcht M, Thomas M. Angiogenesis in malignant melanoma. J Dtsch Der-
matol Ges 2015; 13: 125–136.
3 Gaustad JV, Simonsen TG, Andersen LMK, Rofstad EK. Vascular abnor-
malities and development of hypoxia in microscopic melanoma xeno-
grafts. J Transl Med 2017; 15: 241.
4 Lee J, Abdeen AA, Hedhli J et al. Melanoma topology reveals a stem-like
phenotype that promotes angiogenesis. Sci Adv 2017; 3: e1701350.
5 Huang R, Andersen LMK, Rofstad EK. Metastatic pathway and the
microvascular and physicochemical microenvironments of human mela-
noma xenografts. J Transl Med 2017; 15: 203.
6 Wrobel LJ, Le Gal FA. Inhibition of human melanoma growth by a non-
cardioselective b-blocker. J Invest Dermatol 2015; 135: 525–531.
7 Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and
evolving paradigms. Cell 2011; 147: 275–292.
8 Bgatova NP, Lomakin AI, Fursov SA et al. Expression of molecular mark-
ers of angiogenesis, lymphangiogenesis, and proliferation depending on
the stage of skin melanoma. Bull Exp Biol Med 2016; 161: 542–546.
9 Pastushenko I, Van den Eynden GG, Vicente-Arregui S et al. Increased
angiogenesis and lymphangiogenesis in metastatic sentinel lymph nodes
is associated with nonsentinel lymph node involvement and distant
metastasis in patients with melanoma. Am J Dermatopathol 2016; 38:
338–346.
10 Zalaudek I, Kreusch J, Giacomel J, Ferrara G, Catricala C, Argenziano G.
How to diagnose nonpigmented skin tumors: a review of vascular struc-
tures seen with dermoscopy: part I. Melanocytic skin tumors. J Am Acad
Dermatol 2010; 63: 361–374.
11 Ulrich M, Themstrup L, de Carvalho N et al. Dynamic optical coherence
tomography in dermatology. Dermatology 2016; 232: 298–311.
12 Lindsø Andersen P, Olsen J, Friis KBE et al. Vascular morphology in nor-
mal skin studied with dynamic optical coherence tomography. Exp Der-
matol 2018; 27: 966–972.
13 Themstrup L, Pellacani G, Welzel J, Holmes J, Jemec GBE, Ulrich M. In
vivo microvascular imaging of cutaneous actinic keratosis, Bowen’s dis-
ease and squamous cell carcinoma using dynamic optical coherence
tomography. J Eur Acad Dermatol Venereol 2017; 31: 1655–1662.
14 Themstrup L, De Carvalho N, Nielsen SM et al. In vivo differentiation of
common basal cell carcinoma subtypes by microvascular and structural
imaging using dynamic optical coherence tomography. Exp Dermatol
2018; 27: 156–165.
15 De Carvalho N, Ciardo S, Cesinaro AM et al. In vivo micro-angiography
by means of speckle-variance optical coherence tomography (SV-OCT) is
able to detect microscopic vascular changes in naevus to melanoma tran-
sition. J Eur Acad Dermatol Venereol 2016; 30: e67–e68.
16 De Carvalho N, Welzel J, Schuh S et al. The vascular morphology of mela-
noma is related to Breslow index: an in vivo study with dynamic optical
coherence tomography. Exp Dermatol 2018; 27: 1280–1286.
17 Gershenwald JE, Scolyer RA. Melanoma staging: American Joint Com-
mittee on Cancer (AJCC) 8th Edition and Beyond. Ann Surg Oncol 2018;
25: 2105–2110
18 Ulrich M, Themstrup L, de Carvalho N et al. Dynamic optical coherence
tomography of skin blood vessels - proposed terminology and practical
guidelines. J Eur Acad Dermatol Venereol 2018; 32: 152–155.
19 Skalet AH, Li Y, Lu CD et al. Optical coherence tomography angiography
characteristics of iris melanocytic tumors. Ophthalmology 2017; 24: 197–
204.
© 2020 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd
on behalf of European Academy of Dermatology and Venereology
JEADV 2021, 35, 1087–1093
1092 Welzel et al.
20 Valverde-Megıas A, Say EA, Ferenczy SR, Shields CL. Differential macular
features on optical coherence tomography angiography in eyes with chor-
oidal nevus and melanoma. Retina 2017; 37: 731–740.
21 Tejera-Vaquerizo A, Arias-Santiago S, Nagore E et al. Defining the der-
moscopic characteristics of fast-growing cutaneous melanomas. Mela-
noma Res 2015; 25: 269–272.
22 Mun JH, Jo G, Darmawan CC et al. Association between Breslow thick-
ness and dermoscopic findings in acral melanoma. J Am Acad Dermatol
2018; 79: 831–835.
23 Gonzalez-Alvarez T, Carrera C, Bennassar A et al. Dermoscopy structures
as predictors of sentinel lymph node positivity in cutaneous melanoma.
Br J Dermatol 2015; 172: 1269–1277.
24 Tanaka Y. Impact of near-infrared radiation in dermatology. Review.
World J Dermatol 2012; 1: 30–37.
25 Meyer N, Lauwers-Cances V, Lourari S et al. High-frequency ultrasonog-
raphy but not 930-nm optical coherence tomography reliably evaluates
melanoma thickness in vivo: a prospective validation study. Br J Dermatol
2014; 171: 799–805.
26 Vilana R, Puig S, Sanchez M et al. Preoperative assessment of cutaneous
melanoma thickness using 10-MHz sonography. AJR Am J Roentgenol
2009; 193: 639–643.
27 Hinz T, Ehler LK, Voth H et al. Assessment of tumor thickness in mela-
nocytic skin lesions: comparison of optical coherence tomography, 20-
MHz ultrasound and histopathology. Dermatology 2011; 223: 161–168.
28 Omar M, Schwarz M, Soliman D, Symvoulidis P, Ntziachristos V.
Pushing the optical imaging limits of cancer with multi-frequency-
band raster-scan optoacoustic mesoscopy (RSOM). Neoplasia 2015;
17: 208–214.
© 2020 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd
on behalf of European Academy of Dermatology and Venereology
JEADV 2021, 35, 1087–1093
D-OCT of blood vessels in malignant melanoma 1093
